Table 2.
Clinicopathologic and Biologic Factors that Affect the Survival Rate
| Univariate analysis |
Multivariate analysis |
|||||
|---|---|---|---|---|---|---|
| Variable | RR | 95% CI | P value | RR | 95% CI | P value |
| Age at diagnosis: >1 year versus ≤1 year | 3.969 | 1.666–9.459 | 0.002 | 1.996 | 0.649–6.141 | 0.228 |
| Clinical stage: advanced (3, 4) versus early (1, 2, 4S) | 19.201 | 4.611–79.962 | <0.001 | 6.706 | 1.271–35.395 | 0.025 |
| MYCN: amplified versus nonamplified | 4.241 | 2.255–7.977 | <0.001 | 3.086 | 1.488–6.402 | 0.002 |
| B4GALNT3 expression: negative versus positive | 3.830 | 1.947–7.534 | <0.001 | 2.29 | 1.080–4.853 | 0.031 |
| Histologic profile: unfavorable versus favorable | 3.59 | 1.813–7.019 | <0.001 | 1.438 | 0.656–3.152 | 0.365 |
RR, relative risk.